Department of Haematogenetics, National Institute of Immunohaematology, Mumbai, India.
MCGM Comprehensive Thalassemia Care Pediatric Hematology-Oncology and Bone Marrow Transplantation Centre, Mumbai, India.
J Clin Pathol. 2019 Jun;72(6):393-398. doi: 10.1136/jclinpath-2019-205718. Epub 2019 Mar 27.
Adenylate kinase (AK) deficiency is a rare erythroenzymopathy associated with hereditary nonspherocytic haemolytic anaemia along with mental/psychomotor retardation in few cases. Diagnosis of AK deficiency depends on the decreased level of enzyme activity in red cell and identification of a mutation in the gene. Until, only eight mutations causing AK deficiency have been reported in the literature. We are reporting two novel missense mutation (c.71A > G and c.413G > A) detected in the gene by next-generation sequencing (NGS) in a 6-year-old male child from India. Red cell AK enzyme activity was found to be 30% normal. We have screened a total of 32 family members of the patient and showed reduced red cell enzyme activity and confirm mutations by Sanger's sequencing. On the basis of Sanger sequencing, we suggest that the proband has inherited a mutation in gene exon 4 c.71A > G (p.Gln24Arg) from paternal family and exon 6 c.413G > A (p.Arg138His) from maternal family. Bioinformatics tools, such as SIFT, Polymorphism Phenotyping v.2, Mutation Taster, MutPred, also confirmed the deleterious effect of both the mutations. Molecular modelling suggests that the structural changes induced by p.Gln24Arg and p.Arg138His are pathogenic variants having a direct impact on the structural arrangement of the region close to the active site of the enzyme. In conclusion, NGS will be the best solution for diagnosis of very rare disorders leading to better management of the disease. This is the first report of the red cell AK deficiency from the Indian population.
腺嘌呤激酶(AK)缺乏症是一种罕见的红细胞酶病,与遗传性非球形红细胞溶血性贫血有关,少数情况下还伴有精神/运动发育迟缓。AK 缺乏症的诊断取决于红细胞中酶活性水平降低,并在 基因中发现突变。直到目前,文献中仅报道了 8 种导致 AK 缺乏的突变。我们报告了在一名来自印度的 6 岁男童的 基因中通过下一代测序(NGS)检测到的两种新的错义突变(c.71A > G 和 c.413G > A)。红细胞 AK 酶活性发现为正常的 30%。我们总共筛查了患者的 32 名家庭成员,并通过 Sanger 测序显示出红细胞酶活性降低,并证实了突变。基于 Sanger 测序,我们推测先证者从父系家族遗传了 基因外显子 4 的突变 c.71A > G(p.Gln24Arg),从母系家族遗传了外显子 6 的突变 c.413G > A(p.Arg138His)。生物信息学工具,如 SIFT、Polymorphism Phenotyping v.2、Mutation Taster、MutPred 也证实了这两种突变的有害影响。分子建模表明,p.Gln24Arg 和 p.Arg138His 诱导的结构变化是致病性变异体,直接影响酶活性部位附近区域的结构排列。总之,NGS 将是诊断导致疾病更好管理的非常罕见疾病的最佳解决方案。这是印度人群中首次报道红细胞 AK 缺乏症。